Primed to Thrive: Investigating the Combined Impact of Mindfulness Education and Meditation Practice on Psychological and Workplace Outcomes (BEGIN III)

May 12, 2026 updated by: Balachundhar Subramaniam, Beth Israel Deaconess Medical Center

Primed to Thrive: Investigating the Combined Impact of Mindfulness Education and Meditation Practice on Psychological and Workplace Outcomes (BEGIN III)

Employees commonly experience stress and reduced well-being that can affect workplace functioning. This interventional study will evaluate whether combining mindfulness-related educational materials with a brief daily guided meditation practice delivered through a smartphone application improves psychological well-being and workplace outcomes compared with educational materials alone. Adult employees will be randomized to receive the meditation plus educational materials during the initial intervention period or after a waitlist period, with assessments completed at multiple time points over approximately 12 weeks. The primary outcome will evaluate change in work engagement using the Utrecht Work Engagement Scale (UWES-9).

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

134

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Individuals aged 18 years or older.
  • Current employee of the participating company who expresses interest in participating in the study.
  • Subjects will be required to be able to understand study instructions and materials and provide informed consent.
  • Willing and able to download and use a smartphone application compatible with iOS or Android platforms.

Exclusion Criteria:

  • Insufficient proficiency in English to comprehend study materials and instructions.
  • Presence of a diagnosed mental health condition that may interfere with the capacity to engage in or benefit from meditation practices, as determined by self-report or clinical history.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
Behavioral: Meditation
Participants engage in a minimum of 7 minutes of daily guided meditation via the Miracle of Mind program, delivered through the 3C's app, during their assigned intervention period (Weeks 1-4 for the intervention group; Weeks 5-8 for the waitlist control group). The practice involves voice-guided seated meditation with simple breathing techniques and chants. App- and email-based reminders are provided during the active intervention period only.
Behavioral: Mindful Educational Material
Participants receive access to work-related mindfulness educational materials throughout the full 12-week study period via the 3C's app. Materials are derived from Sadhguru's teachings and address topics including stress management, communication, and work-life balance. Both groups receive these materials to ensure comparable engagement and provide a control condition for evaluating the specific effects of meditation.
Active Comparator: Waitlist Control Group
Behavioral: Meditation
Participants engage in a minimum of 7 minutes of daily guided meditation via the Miracle of Mind program, delivered through the 3C's app, during their assigned intervention period (Weeks 1-4 for the intervention group; Weeks 5-8 for the waitlist control group). The practice involves voice-guided seated meditation with simple breathing techniques and chants. App- and email-based reminders are provided during the active intervention period only.
Behavioral: Mindful Educational Material
Participants receive access to work-related mindfulness educational materials throughout the full 12-week study period via the 3C's app. Materials are derived from Sadhguru's teachings and address topics including stress management, communication, and work-life balance. Both groups receive these materials to ensure comparable engagement and provide a control condition for evaluating the specific effects of meditation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Work Engagement (UWES-9)
Time Frame: Baseline T1 toT2 - Intervention Phase I (Weeks 1-4)
To examine the changes in psychological and workplace outcomes associated with a combined intervention of mindfulness-related educational materials and meditation practice versus educational materials alone.
Baseline T1 toT2 - Intervention Phase I (Weeks 1-4)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stress (PSS)
Time Frame: Baseline T1 to T4 ((Week 1- Week 12)
To investigate the durability of improvements in psychological and workplace outcomes following the meditation + education intervention compared with the education-only condition.
Baseline T1 to T4 ((Week 1- Week 12)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mood and Mental Health (SPANE)
Time Frame: Baseline T1 to T4 ((Week 1- Week 12)
To explore whether individual differences in meditation engagement are associated with greater outcome improvements.
Baseline T1 to T4 ((Week 1- Week 12)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Beth Israel Deaconess Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

April 10, 2026

First Submitted That Met QC Criteria

April 10, 2026

First Posted (Actual)

April 16, 2026

Study Record Updates

Last Update Posted (Actual)

May 14, 2026

Last Update Submitted That Met QC Criteria

May 12, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2026P000023

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Workplace Wellbeing

Clinical Trials on Meditation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe